NSC |
Compound |
Enrichment |
Correlation |
NSC 659949 |
14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone |
0.045446901295916 |
0.34392342 |
NSC 660636 |
2-[1-(4-(4'-acetophenone)piperazino)]-naphthazarin |
0.045446901295916 |
0.21044981 |
NSC 675000 |
Null |
0.045446901295916 |
0.40249246 |
NSC 676372 |
Null |
0.045446901295916 |
0.30369947 |
NSC 677776 |
Null |
0.045446901295916 |
0.0094450132 |
NSC 682866 |
Ethanone, 1-[7-(4-chlorophenyl)-5,6-dihydro-9-methyl- 7H-benzo[h]thiazolo[2,3-b]quinazolin-10-yl]- |
0.0454469012959163 |
0.16748487 |
NSC 144173 |
Quinoxaline, 2,3-bis(iodomethyl)-6-methoxy- |
0.0454469012959166 |
0.1808358 |
NSC 368697 |
Benz[a]anthracene-1,7,12(12b-H)-trione, 2,3,4,4a-tetra- hydro-2,3,4a,8,12a-pentahydroxy-3-methyl- |
0.0454469012959166 |
-0.0083697905 |
NSC 625498 |
4-Morpholinecarbodithioic acid, antimony complex |
0.0454469012959166 |
0.11954425 |
NSC 632790 |
Platinum, dichloro(quinoline-N)[sulfinylbis(methane)-S]-, (SP-4-1) |
0.0454469012959166 |
0.23675459 |